❤️
Splenomegaly — Assessment & ManagementEBV rupture risk · CML (haematology-led) · portal hypertension · Gaucher · myelofibrosis · hypersplenism · post-splenectomy OPSI · lymphoma suspected cancer referral
Progress0 / 9

⚡ Snapshot. The whole pathway on one page: act now, triage, classify, treat today and safety-net. The Steps tab holds the detail.

Open full screen ↗
1
Safety

Red Flags — Splenic Rupture, Malignancy & Acute Emergencies

Sudden severe left upper quadrant or left shoulder-tip pain with known or suspected splenomegaly, EBV or recent trauma — especially with syncope, tachycardia, hypotension or peritonism Possible splenic rupture (differentials: splenic infarction, subcapsular haematoma, pancreatitis, renal pathology, pneumonia, pulmonary embolism, musculoskeletal pain). → Call 999, keep the patient supine and warm, avoid oral intake, apply standard major-trauma/haemorrhage principles, obtain IV access if trained and equipped, and transfer immediately to hospital. Do not delay transfer for investigations or fluid administration. Spontaneous rupture can occur in infectious mononucleosis (rare): avoid contact/collision sports and abdominal-trauma risk during the acute illness and while the spleen remains enlarged. Trauma risk is especially relevant in acute infection and marked enlargement.
Splenomegaly + fever + night sweats + weight loss + lymphadenopathy Haematological malignancy (lymphoma — particularly Hodgkin's, NHL, CLL; acute leukaemia). Consider suspected cancer pathway referral (NICE NG12). FBC with differential + blood film, LDH, LFTs. Do not delay referral for extensive GP imaging unless part of the local pathway — CT is not a routine GP first-line test.
Splenomegaly + persistent unexplained leukocytosis (neutrophilia with left shift, basophilia, thrombocytosis) + constitutional symptoms/early satiety Suspect chronic myeloid leukaemia (CML) — splenomegaly can be massive. CML can present with considerably lower WBC counts, and extreme leukocytosis has a broad differential: diagnosis requires a blood film and confirmation of BCR::ABL1 (Philadelphia chromosome), not the WBC level alone. Arrange urgent haematology assessment and BCR::ABL1 testing according to the local pathway.
Splenomegaly + signs of portal hypertension (ascites, varices, caput medusae) + jaundice + liver disease history Portal hypertension from cirrhosis → congestive splenomegaly + hypersplenism (pancytopenia). Risk of variceal haemorrhage. 999 if haematemesis or melaena. Hepatology referral.
Marked or rapidly enlarging splenomegaly of any cause Requires urgent investigation and specialist assessment, especially with pain, cytopenias, B symptoms, abnormal blood film or early satiety. Urgency depends on symptoms, rate of growth, cytopenias, abdominal complications and suspected cause — it is not automatically an emergency and does not by itself imply infarction or imminent rupture. Advise avoidance of activities with a meaningful risk of abdominal trauma while assessment is pending, and not to palpate the spleen.
Splenomegaly + travel history + fever + malaise + anaemia Visceral leishmaniasis (kala-azar — Leishmania donovani), malaria (Plasmodium vivax/malariae cause chronic splenomegaly), schistosomiasis (portal hypertension). Urgent malaria testing if fever after relevant travel; urgent infectious diseases/tropical medicine advice.
Splenic rupture in infectious mononucleosis is a rare but life-threatening complication — occurring in approximately 0.1–0.5% of EBV cases, most commonly in the second to third week of illness when splenic enlargement peaks. The spleen in EBV is infiltrated with EBV-infected lymphocytes and becomes fragile and susceptible to rupture from relatively minor trauma (including vigorous palpation, contact sports, or even coughing). The clinical implication: all patients with confirmed or suspected EBV infectious mononucleosis should be advised to avoid contact or collision sports, strenuous exertion, heavy lifting and activities with a risk of abdominal trauma during the acute illness and while the spleen remains enlarged. The duration should be individualised according to symptoms, clinical recovery, sport and specialist/local advice — avoid contact sport for at least 4 weeks from symptom onset (NICE CKS); beyond that there is no validated clearance rule. GPs should not routinely palpate the spleen vigorously in a patient with suspected EBV — a gentle examination or ultrasound is safer. Any patient with EBV who develops sudden left upper quadrant pain requires emergency assessment for rupture or infarction — 999 if severe, after trauma, or with syncope, tachycardia, hypotension or peritonism. The return to contact sports after EBV should be guided by resolution of symptoms, clinical recovery, the sport and normal abdominal examination. Routine ultrasound to clear return to sport is not required for every patient, and ultrasound normalisation does not establish zero risk.
2
Diagnose

Causes of Splenomegaly — Classification

Haematological (most important in primary care to identify)
Lymphoma (Hodgkin's and NHL — spleen is part of lymphoid tissue): splenomegaly ± peripheral lymphadenopathy ± B symptoms. Leukaemia: CML (massive splenomegaly, BCR-ABL+), CLL (moderate, FBC shows lymphocytosis), AML/ALL (variable). Myelofibrosis (teardrop poikilocytes on blood film, massive splenomegaly — extramedullary haematopoiesis). Polycythaemia vera (PV — raised Hb + splenomegaly + JAK2 mutation). Haemolytic anaemias (hereditary spherocytosis, sickle cell — splenomegaly from haemolysis until autosplenectomy).
Infections
EBV (infectious mononucleosis): most common acute cause in young adults — fever + pharyngitis + cervical lymphadenopathy + splenomegaly. Malaria (Plasmodium vivax/malariae — chronic splenomegaly in hyperreactive malarial splenomegaly). Visceral leishmaniasis (kala-azar — massive splenomegaly + fever + weight loss). Bacterial endocarditis (septic emboli). Brucellosis. TB. Schistosomiasis (portal fibrosis).
Liver disease / portal hypertension
Cirrhosis (any cause — alcoholic, viral hepatitis, NAFLD/NASH) → portal hypertension → congestive splenomegaly + hypersplenism (pancytopenia from sequestration). Hepatic vein thrombosis (Budd-Chiari — findings such as ascites and hepatomegaly are non-specific; abdominal pain, ascites, hepatomegaly and hepatic dysfunction need urgent imaging and specialist assessment). Portal vein thrombosis.
Inflammatory / immunological
Sarcoidosis (non-caseating granulomas in spleen). SLE (immune-mediated splenomegaly). Rheumatoid arthritis (Felty syndrome — splenomegaly + neutropenia + RA — treat with methotrexate). Amyloidosis.
Storage diseases / infiltrative
Gaucher disease (glucocerebrosidase deficiency — massive splenomegaly + pancytopenia + bone pain). Niemann-Pick disease. Glycogen storage diseases. Amyloidosis. Extramedullary haematopoiesis (myelofibrosis, thalassaemia).
The mnemonic for causes of massive splenomegaly (extending to or beyond the umbilicus) is clinically useful: CML (Chronic Myeloid Leukaemia), Myelofibrosis, Malaria (chronic), Leishmaniasis, and Gaucher disease — these five conditions characteristically cause the largest spleens. A very large spleen should prompt urgent investigation and specialist assessment; urgency depends on symptoms, rate of growth, cytopenias, complications and suspected cause. The spleen in CML can weigh up to 5 kg — early satiety from gastric compression, left-sided pleuritic pain from splenic infarction, and referred left shoulder pain (Kehr's sign) are characteristic symptoms. Felty syndrome deserves specific mention as a commonly tested condition — it is the triad of: rheumatoid arthritis (typically seropositive, long-standing) + splenomegaly + neutropenia (ANC <2 × 10⁹/L). The mechanism is complex: splenic sequestration of neutrophils + anti-neutrophil antibodies + granulopoiesis suppression. The clinical significance: patients with Felty syndrome have a high risk of recurrent bacterial infections (from neutropenia), leg ulcers, and lymphoma (7× increased risk compared to RA without Felty). Treatment: methotrexate or biological DMARDs for RA control; G-CSF for severe neutropenia; splenectomy in rare refractory cases.
3
Diagnose

Assessment — Examination Technique & Investigations

Spleen examination technique
Start in RIF (right iliac fossa) and move diagonally toward LUQ (left upper quadrant) with the patient in supine position. Use fingertip palpation on inspiration (spleen descends). Ask patient to take deep breaths. Move in 2-cm increments. Once spleen is palpable: measure in cm below left costal margin at its maximum extent in the mid-clavicular line. Note: a normal spleen is not palpable (need approximately 2–3× normal size before palpable). Examination findings (spleen size below the costal margin, plethoric facies, pruritus, gout, palpable kidneys) are clinical clues only: a non-palpable spleen does not exclude significant enlargement, and a palpable spleen does not identify the cause. Confirm with USS if in doubt or if percussion suggests enlargement (normally resonant in Traube's space = spleen not enlarged).
Imaging — clinically directed
USS abdomen to confirm suspected splenomegaly when not already demonstrated (repeat USS is unnecessary if already shown on CT/MRI), and to assess liver morphology, portal hypertension, focal splenic lesions and associated hepatomegaly. Measured spleen length is affected by body habitus, respiratory phase and imaging technique — size categories (e.g. >12 cm enlarged) are local radiology conventions, not referral thresholds. Identifies: hepatomegaly (portal hypertension), portal vein diameter (>13 mm = portal hypertension), hepatic nodularity (cirrhosis), ascites, para-aortic lymphadenopathy. Avoids need to palpate a potentially fragile spleen. CT or MRI when ultrasound is inconclusive, malignancy is suspected, complications are present or detailed staging is required — not routine for every patient; appropriate with B symptoms, lymphadenopathy, abnormal film or cytopenias, suspected lymphoma/leukaemia/myeloproliferative neoplasm, focal lesions, portal or splenic vascular complications, or concerning constitutional symptoms. For suspected lymphoma, do not delay referral for GP imaging unless part of the local pathway.
Investigations (initial GP panel — prioritised)
FBC + differential + blood film (essential — lymphocytosis + atypical lymphocytes = EBV; leukaemic cells; tear-drop poikilocytes = myelofibrosis; spherocytes = haemolytic anaemia) · Reticulocytes, bilirubin, LDH, haptoglobin if anaemia or haemolysis possible · Renal function + electrolytes · LFTs incl. bilirubin + albumin, calcium · LDH · CRP/ESR if inflammatory or infective disease suspected · Ferritin, B12, folate where cytopenia or anaemia · EBV/CMV/HIV or other infection tests only when clinically indicated · Malaria film/RDT urgently if fever after relevant travel · Pregnancy test where relevant. Not every patient needs broad testing for HLH, Gaucher disease, tropical infection and malignancy simultaneously; ANA/RF/complement only if an inflammatory cause is suspected; very high ferritin with fever and cytopenias → consider HLH.
Investigations (targeted)
Suspected portal hypertension: LFTs + coagulation + USS + fibroscan. Suspected CML: BCR::ABL1 testing per local pathway (peripheral blood). Suspected myelofibrosis: bone marrow biopsy (haematology). Suspected Gaucher: glucocerebrosidase enzyme assay + chitotriosidase. Suspected lymphoma: suspected cancer pathway referral (imaging and biopsy specialist/pathway-directed). Suspected leishmaniasis: serology + bone marrow biopsy.
The blood film is as crucial for splenomegaly as it is for anaemia — the peripheral blood film provides direct morphological evidence of the underlying diagnosis in many cases of splenomegaly. Key findings: atypical lymphocytes + monospot positive = EBV (but monospot may be negative in the first 7 days, negative in young children, and falsely negative in elderly); blast cells = acute leukaemia; smear cells (Gumprecht shadows) + lymphocytosis = CLL; teardrop poikilocytes (dacrocytes) + leucoerythroblastic picture = myelofibrosis; spherocytes + reticulocytosis = hereditary spherocytosis or autoimmune haemolytic anaemia; left-shifted granulocytes (band forms, metamyelocytes, myelocytes, promyelocytes) = CML or leukaemoid reaction; ring sideroblasts = MDS. The haematologist's review of the blood film should be requested urgently for any patient with unexplained splenomegaly — the result will direct the next investigation step more efficiently than any algorithm.
4
Diagnose

Severity & Urgency Classification

Emergency
Splenic rupture (trauma + splenomegaly, sudden LUQ pain + shock) · Haematemesis + varices + portal hypertension · Blood film suggestive of acute leukaemia · Acute severe LUQ pain with syncope, peritonism or falling haemoglobin · Sepsis or rapid deterioration in a patient with absent/dysfunctional spleen
Suspected cancer: haematology
Unexplained adult splenomegaly → FBC with differential + blood film and consider suspected cancer pathway referral for non-Hodgkin lymphoma (NICE NG12), taking account of fever, night sweats, breathlessness, pruritus and weight loss · Adults with hepatosplenomegaly or other features of leukaemia → consider a very urgent FBC (within 48 hours) · Children and young people with unexplained hepatosplenomegaly → immediate specialist assessment for leukaemia; unexplained splenomegaly → consider a very urgent referral (within 48 hours) for non-Hodgkin lymphoma · Abnormal film, blasts, marked leukocytosis, cytopenias, B symptoms, lymphadenopathy, hepatomegaly or rapidly enlarging spleen → urgent haematology · Suspected CML (persistent leukocytosis, left shift, basophilia, thrombocytosis) → urgent haematology + BCR::ABL1. A normal or mildly abnormal WBC does not exclude lymphoma, CLL or myelofibrosis; spleen size and WBC are not NICE referral thresholds.
Urgent specialist assessment (local pathway)
Persistent unexplained splenomegaly without clear benign cause · Splenomegaly + hypersplenism (cytopenias) · Persistent splenomegaly or symptoms after clinical recovery from EBV · Known cirrhosis with portal hypertension → hepatology pathway · Travel-related fever/splenomegaly → urgent infectious diseases/tropical medicine advice
GP investigation and watchful waiting
Mild splenomegaly in context of acute EBV (expected and transient — clinical follow-up; routine USS not required) · Cirrhosis-related splenomegaly (stable, cause known) · Hereditary spherocytosis (known, stable)
Haemophagocytic lymphohistiocytosis (HLH) is a rare but life-threatening condition associated with splenomegaly that GPs must recognise — it is characterised by: fever (prolonged), splenomegaly, cytopenias (at least 2 cell lines), hyperferritinaemia (often very high — a very high ferritin with fever and cytopenias should trigger same-day haematology contact), hypertriglyceridaemia, elevated soluble CD25 (sIL-2R), haemophagocytosis on bone marrow biopsy, and low/absent NK cell activity. HLH can be primary (familial, genetic — young children) or secondary (triggered by infection — most commonly EBV, or malignancy — particularly T-cell lymphoma, or autoimmune disease — SLE, adult-onset Still's disease). The key primary care recognition point: a patient with unexplained prolonged fever + splenomegaly + falling blood counts + very high ferritin should prompt same-day haematology contact. HLH is life-threatening if untreated; treatment is specialist-led.
5
Refer

Referral Pathways

999
Suspected splenic rupture or haemodynamic instability · Haematemesis/melaena (variceal haemorrhage) · Asplenic patient with fever and collapse, confusion, severe breathlessness, meningism, rapid deterioration or haemodynamic instability · (Blood film suggesting acute leukaemia → same-day haematology)
Suspected cancer: haematology
Unexplained splenomegaly + B symptoms/lymphadenopathy · Suspected lymphoma or leukaemia · Marked or rapidly enlarging unexplained splenomegaly · NICE NG12 (updated April 2026): in adults, consider a suspected cancer pathway referral for non-Hodgkin lymphoma when splenomegaly is unexplained, taking into account fever, night sweats, breathlessness, pruritus or weight loss; consider a very urgent FBC (within 48 hours) for hepatosplenomegaly or other features suggestive of leukaemia · Children and young people: unexplained hepatosplenomegaly → immediate specialist assessment for leukaemia; unexplained splenomegaly → consider a very urgent referral (within 48 hours) for non-Hodgkin lymphoma
Hepatology (urgent)
Portal hypertension + cirrhosis + splenomegaly (variceal surveillance — OGD) · Abnormal LFTs + splenomegaly without haematological cause
Haematology (urgent, local pathway)
Persistent unexplained splenomegaly · Abnormal film, blasts, marked leukocytosis, cytopenias, B symptoms or rapidly enlarging spleen · Hypersplenism (cytopenias) · Myeloproliferative neoplasm suspected
Tropical medicine / infectious diseases
Travel-related fever/splenomegaly (malaria, leishmaniasis, schistosomiasis, brucellosis) — urgent advice; urgent malaria testing if fever after relevant travel
Rheumatology
Felty syndrome (RA + splenomegaly + neutropenia) · SLE-related · Sarcoidosis
GP management
Confirmed EBV splenomegaly: clinical follow-up (USS only if persistent symptoms, ongoing pain or enlargement), avoid contact/collision sports for at least 4 weeks (NICE CKS) and while enlarged, call 999 for sudden severe LUQ or left shoulder-tip pain. Portal hypertension from known cirrhosis: stable management + hepatology follow-up. Known haematological cause: specialist-led.
Local pathways
Use your local haematology, hepatology and immunisation pathways.
The OGD (oesophagogastroduodenoscopy) surveillance for varices in portal hypertension follows NICE NG50 (updated 2023) — after a diagnosis of cirrhosis, offer upper GI endoscopy (unless starting carvedilol or propranolol to prevent decompensation); in practice any patient with confirmed portal hypertension should have an OGD to assess for oesophageal and gastric varices. If large varices are found: primary prophylaxis with non-selective beta-blocker (carvedilol or propranolol per the hepatology/current portal-hypertension pathway — do not initiate or titrate propranolol solely from spleen size) or endoscopic variceal ligation (EVL). GPs managing patients with cirrhosis and splenomegaly must ensure: (1) the patient is under hepatology follow-up; (2) the OGD surveillance is up to date (every 3 years if no varices on the first endoscopy — NICE NG50; more often if small varices, per the hepatology team); (3) the patient has been warned about variceal haemorrhage warning signs (haematemesis, melaena, sudden dizziness) and instructed to call 999 immediately. Acute variceal bleeding carries significant mortality — prevention with primary prophylaxis under the hepatology pathway is preferable.
6
Treat

Management by Cause

EBV splenomegaly
Supportive + monitoring
Paracetamol/ibuprofen for fever + pain. Avoid contact/collision sports, strenuous exertion and abdominal-trauma risk for at least 4 weeks from symptom onset (NICE CKS) and while the spleen remains enlarged (routine USS clearance not required). Call 999 for sudden severe LUQ/shoulder-tip pain. Corticosteroids are not routinely indicated for uncomplicated EBV; consider for impending or established upper-airway obstruction, severe immune thrombocytopenia (judged on bleeding and platelet count, not an isolated low count), autoimmune haemolytic anaemia, or selected severe complications under specialist advice. Antibiotics NOT indicated (viral).
CML
Tyrosine kinase inhibitor (haematology-led)
TKI choice, dose and monitoring depend on disease phase, molecular response, adverse effects, interactions and specialist protocol. Haematology-initiated; GP prescribing and blood monitoring only under a current written shared-care protocol.
Portal hypertension splenomegaly
Treat underlying liver disease
Alcohol cessation (cirrhosis). Antiviral therapy (hepatitis B/C — hepatology). NASH: weight loss + GLP-1 agonist (emerging). Manage with hepatology input: variceal screening and non-selective beta-blocker treatment (e.g. carvedilol or propranolol) per the current cirrhosis/portal-hypertension pathway — do not initiate or titrate propranolol solely from spleen size. Splenectomy is not a routine option for hypersplenism in portal hypertension.
Gaucher disease
Specialist Gaucher service
Refer to a specialist Gaucher/lysosomal storage disorder service (e.g. Royal Free Hospital, London). Treatment choice (enzyme replacement or substrate reduction therapy), regimen and frequency are determined by the specialist service.
Myelofibrosis
Specialist haematology management
JAK inhibitors such as ruxolitinib are specialist treatment for selected patients with myelofibrosis (not a general treatment for splenomegaly) and require monitoring for cytopenias, infection and withdrawal effects. HSCT may be curative in eligible patients.
Gaucher disease (type 1 — non-neuropathic) is one of the most rewarding rare disease diagnoses to make in primary care because specialist treatment can substantially improve splenomegaly, cytopenias and bone disease — treatment choice and regimen are determined by the specialist Gaucher service. The challenge is that Gaucher disease is underdiagnosed (estimated prevalence 1 in 40,000–60,000, but Ashkenazi Jewish prevalence 1 in 450) and the diagnosis is often delayed by years because the symptoms mimic more common conditions (anaemia, splenomegaly from 'portal hypertension'). The diagnostic clue: massive splenomegaly + pancytopenia + bone pain (Erlenmeyer flask deformity on X-ray — widening of the distal femur) in a patient with no evidence of haematological malignancy or portal hypertension. Serum chitotriosidase (a macrophage enzyme elevated in Gaucher disease) is an excellent screening test — dramatically elevated (>1000 nmol/h/ml vs normal <100). Glucocerebrosidase enzyme assay on a dried blood spot is diagnostic.
7
Treat

Hypersplenism, Splenectomy & Post-Splenectomy

Hypersplenism management
Hypersplenism (pancytopenia from excessive splenic sequestration): treat the underlying cause primarily. Use restrictive transfusion principles, but individualise red-cell and platelet transfusion according to symptoms, active bleeding, procedural requirements and specialist/transfusion guidance. Splenectomy is not a general treatment for pancytopenia — usually reserved, after multidisciplinary assessment, for severe symptomatic hypersplenism not responding to medical treatment, severe haemolytic anaemia (hereditary spherocytosis), ITP refractory to medical treatment. Partial splenic embolisation: alternative to splenectomy in portal hypertension.
Splenectomy indication and planning
Hereditary spherocytosis (definitive treatment — typically delayed until age 6 to preserve immune development). Chronic ITP refractory to steroids + rituximab + thrombopoietin agonists. Symptomatic hereditary haemolytic anaemias. Staging laparotomy (now rarely done for lymphoma). Planning: vaccinate at least 2 weeks before elective splenectomy — pneumococcal PCV20 per the current UKHSA Green Book chapter 25 (PCV20 replaced PPV23 for clinical risk groups aged 2 years and over in 2026; asplenia and splenic dysfunction need revaccination every 5 years), MenACWY and MenB (age-dependent schedules — check the current Green Book chapters at each review). Ensure routine Hib-containing immunisation is complete; additional Hib vaccination is not routinely recommended solely because of asplenia. Post-splenectomy: daily antibiotic prophylaxis with phenoxymethylpenicillin (a macrolide if penicillin-allergic; dose per NICE/SPC) — particularly in the early post-splenectomy period and lifelong in patients at continuing high risk; regimen and duration per current BSH/UKHSA/local policy — + annual flu vaccine.
Post-splenectomy OPSI
Overwhelming Post-Splenectomy Infection (OPSI): medical emergency. Caused by encapsulated bacteria (Streptococcus pneumoniae most common; also Haemophilus influenzae, Neisseria meningitidis). High mortality if not treated promptly. Presentation: rapid-onset fever + rigors + confusion (within hours of first symptom to septic shock). Action: any fever, rigors or systemic illness requires immediate same-day medical assessment. Take the prescribed standby (rescue) antibiotic promptly if advised by the written, patient-specific plan — usually amoxicillin, or the agreed alternative if penicillin-allergic (dose per NICE/SPC) — and do not delay contacting NHS 111, the GP urgent service or emergency services. Call 999 for collapse, confusion, severe breathlessness, meningism, rapidly progressive illness or haemodynamic instability. Standby antibiotics must not delay hospital assessment. Splenectomy patients must carry: written emergency card + spare antibiotic course at home.

Next steps: see Haematological cancers · Glandular fever · Fatty liver (MASLD)

The OPSI (Overwhelming Post-Splenectomy Infection) risk is the most important long-term complication of splenectomy and requires lifelong vigilance — the spleen is the body's primary filter for encapsulated bacteria (which evade phagocytosis without opsonisation by complement and antibody). Without the spleen, these bacteria can cause rapidly fatal septicaemia. The lifetime risk of OPSI is approximately 3–5% (higher in children and in the first 2 years post-splenectomy). Every asplenic patient (surgical splenectomy OR functional asplenia — sickle cell disease, coeliac disease, SLE) should have in their medical record: (1) documentation of vaccinations (pneumococcal PCV20 per the current Green Book chapter 25, revaccinated every 5 years; meningococcal ACWY + B; annual flu; routine Hib-containing immunisation complete); (2) a risk-based prophylactic antibiotic prescription (phenoxymethylpenicillin, or a macrolide if allergic) + a standby course with a standing instruction to take it immediately at first sign of infection; (3) a patient-held emergency card explaining that they are asplenic and require immediate antibiotics; and (4) an alert on the electronic record that displays at every consultation. GPs reviewing asplenic patients at annual review must check: vaccinations up to date? Prophylactic antibiotic prescription current and patient taking it? Standby course in date? Patient knows any fever, rigors or systemic illness needs immediate same-day medical assessment (999 for collapse, confusion, severe breathlessness, meningism or rapid deterioration)?
8
Lifestyle

EBV Prevention, Activity Restrictions & Post-Splenectomy Safety

EBV splenic rupture prevention Avoid contact or collision sports, strenuous exertion, heavy lifting and activities with a risk of abdominal trauma during the acute illness and while the spleen remains enlarged. Duration individualised according to symptoms, clinical recovery, sport and specialist/local advice (avoid contact sport for at least 4 weeks from symptom onset (NICE CKS); beyond that there is no validated clearance rule). Routine ultrasound to clear return to sport is not required for every patient. Written advice; document advice given.
Post-splenectomy vaccine schedule Pre-splenectomy (at least 2 weeks before elective): pneumococcal per the current UKHSA Green Book/BSH 2024 schedule (PCV20, which replaced PPV23 for clinical risk groups aged 2 years and over in 2026), MenACWY, MenB (Bexsero) — schedules differ by age at diagnosis and vaccination history, MenACWY and MenB booster requirements differ, travel indications may apply, and local vaccination services may deliver the programme; check the current Green Book chapters at each review rather than a static table. Ensure routine Hib-containing immunisation is complete; additional Hib vaccination is not routinely recommended solely because of asplenia. Annual influenza (Green Book chapter 19). Post-splenectomy: pneumococcal revaccination with PCV20 every 5 years (asplenia and splenic dysfunction; Green Book chapter 25). If emergency splenectomy: vaccinate 2 weeks post-operatively. Check UKHSA Green Book chapters 7 and 25 for the current schedule. Document in notes and issue asplenia record card.
Antibiotic prophylaxis — risk-based duration Daily oral phenoxymethylpenicillin (penicillin V); a macrolide such as erythromycin if penicillin-allergic — dose per NICE/SPC by age. BSH guideline (2024): offer daily prophylaxis after splenectomy or in significant hyposplenism, particularly during the early post-splenectomy period and lifelong in patients at continuing high risk (e.g. children, the early years after splenectomy, poor vaccine response, previous invasive pneumococcal disease, sickle cell disease, immunocompromise). For lower-risk adults, discuss duration with the responsible specialist, balancing benefit, adherence, antimicrobial resistance and patient preference. Plus a standby course at home as part of a written emergency plan. Document and prescribe at every annual review. If patient declines: document discussion.
OPSI awareness education Educate patient and family: any fever, rigors or systemic illness requires immediate same-day medical assessment. Take the prescribed standby antibiotic promptly if advised by the written plan (usually amoxicillin, or the agreed alternative if penicillin-allergic — dose per NICE/SPC) and do not delay contacting NHS 111, the GP urgent service or emergency services. Call 999 for collapse, confusion, severe breathlessness, meningism, rapidly progressive illness or haemodynamic instability. Show emergency card to all healthcare workers. This is life-saving education — do not assume the patient remembers from years ago.
Travel precautions for asplenic patients Malaria risk: asplenic patients have dramatically increased risk of severe falciparum malaria (spleen filters parasitised RBCs). Pre-travel consultation well in advance; malaria chemoprophylaxis according to destination and current TravelHealthPro advice (DEET and mosquito nets add to, but do not substitute for, chemoprophylaxis); rapid assessment of any fever during or after travel; carry the asplenia card and antibiotic plan; vaccines do not prevent all severe infections. Babesiosis (tick-borne, rare in UK but increasing): asplenic patients at risk of severe disease. Dog tick prevention measures.
Alcohol and cirrhotic splenomegaly Alcohol abstinence is appropriate advice in alcohol-related cirrhosis and portal-hypertensive splenomegaly, but should not be expected to reliably reverse established portal hypertension. NHS referral to community alcohol service (CDAS). AUDIT to assess alcohol use. Relapse-prevention medication requires specialist assessment of liver function, opioid use, renal function and suitability.
Gaucher disease quality of life National Gaucher Centre (Royal Free Hospital, London): specialist multidisciplinary management. Treatment type and frequency are determined by the specialist Gaucher service — home infusion programmes available for some patients. Gauchers Association UK (gaucher.org.uk): patient support. Bone complications: bisphosphonates for osteoporosis (haematology guidance). Decisions about splenectomy are for the specialist Gaucher service.
Activity restrictions in significant splenomegaly Individualise advice according to cause, symptoms, size and rate of enlargement, splenic architecture, sport and trauma risk, and specialist assessment. In marked splenomegaly it is reasonable to advise avoiding contact/collision sports and activities with a risk of abdominal trauma. Written advice documented.
The spleen as a filter for malaria-infected red blood cells explains why asplenic patients are at dramatically increased risk from Plasmodium falciparum malaria — the spleen normally identifies and removes parasitised erythrocytes from the circulation through its unique filtration system (the red pulp cords force red cells through narrow slits that parasitised cells cannot traverse). Without the spleen, parasitised cells circulate unchecked, causing hyperparasitaemia and severe falciparum malaria with a much higher case fatality rate. Asplenic patients travelling to malaria-endemic regions should be counselled particularly strongly about: chemoprophylaxis (not optional — regimen according to destination and current TravelHealthPro advice; DEET and nets do not substitute for it), personal protective measures (DEET 50%+ repellent, long sleeves/trousers at dawn/dusk, permethrin-treated bed nets), and seeking medical attention immediately with any fever within 3 months of return (the travel declaration 'I am asplenic' should be communicated to the treating physician).
9
Safety

Follow-Up, Monitoring & Safety-Netting

EBV splenomegaly
Follow-up guided by symptom persistence, ongoing abdominal pain, splenic enlargement, occupation or sport, prolonged fatigue and mood symptoms identified clinically — routine USS and routine PHQ-9 are not required. Avoid contact/collision sports for at least 4 weeks (NICE CKS) and while the spleen remains enlarged. 999 for sudden severe LUQ/shoulder-tip pain. Post-viral fatigue is common.
Post-splenectomy annual review
Vaccinations up to date (check immunisation record)? Pneumococcal booster due per current Green Book/BSH schedule (PCV20 every 5 years)? Annual flu vaccine given? MenACWY and MenB complete? Antibiotic prophylaxis and standby antibiotic reviewed per risk and local policy? Written emergency plan in place? Patient carrying emergency card? Education refreshed? Travel advice given? Code asplenic status in record.
CML monitoring (shared care)
CML treatment and molecular (BCR::ABL1) monitoring are haematology-led. Primary-care prescribing and blood monitoring should occur only under a current written shared-care protocol.
Portal hypertension splenomegaly
OGD surveillance as per hepatology protocol. Blood monitoring and beta-blocker management per hepatology and the current cirrhosis/portal-hypertension pathway — do not initiate or titrate propranolol solely from spleen size.
999 / Same-day haematology
Sudden severe LUQ or left shoulder-tip pain, especially after trauma or with syncope, tachycardia, hypotension, peritonism or falling haemoglobin → 999 (possible rupture or infarction) · Haematemesis / melaena in portal hypertension → 999 · Asplenic patient with fever, rigors or systemic illness → immediate same-day medical assessment + standby antibiotic per written plan; 999 for collapse, confusion, severe breathlessness, meningism, rapid deterioration or haemodynamic instability · Blood film suggestive of acute leukaemia → same-day haematology
Urgent / suspected cancer pathway
Unexplained new adult splenomegaly → FBC + film and consider suspected cancer pathway referral for non-Hodgkin lymphoma (NICE NG12) via the local referral pathway · Adults with hepatosplenomegaly or features of leukaemia → consider a very urgent FBC (within 48 hours) · Children and young people with unexplained hepatosplenomegaly → immediate specialist assessment · WBC rising in known CML (possible blast transformation) → haematology urgently
The splenomegaly safety-net for splenic rupture must be given verbally AND documented in writing at every consultation where significant splenomegaly is identified — 'If you develop sudden severe left-sided or central abdominal pain, particularly if it spreads to your left shoulder tip (Kehr's sign — referred pain from subphrenic blood), call 999 immediately. Do not drive yourself to hospital. This could mean your spleen has ruptured, which is a surgical emergency.' Kehr's sign (left shoulder tip pain from diaphragmatic irritation by subphrenic blood) is the key referred pain pattern of splenic rupture that can be mentioned to the patient — it is often the presenting symptom before the classical abdominal pain develops. This simple piece of patient education, properly documented, can be life-saving.
Educational use only. Based on NICE NG12 Suspected cancer: recognition and referral, NICE NG52 Non-Hodgkin lymphoma: diagnosis and management, NICE NG50 Cirrhosis in over 16s: assessment and management, NICE PH43 Hepatitis B and C testing, BSH 2024: Prevention and treatment of infection in patients with an absent or hypofunctional spleen, UKHSA Green Book chapter 7: Immunisation of individuals with underlying medical conditions (with chapters 25 and 16 — check the current versions), local haematology, hepatology and immunisation pathways, Bain B et al. Blood film interpretation, BSH CML guidelines 2023.